SHUKRA PHARMACEUTICALS
Back to Income Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹33 Cr | ₹75 Cr | ₹59 Cr | ₹20 Cr | ₹11 Cr |
What is the latest Revenue of SHUKRA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹59 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹11 Cr |
How is Revenue of SHUKRA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | -56.30 | |
| Mar2024 | ₹75 Cr | 26.75 | |
| Mar2023 | ₹59 Cr | 187.19 | |
| Mar2022 | ₹20 Cr | 82.98 | |
| Mar2021 | ₹11 Cr | - | |
Compare Revenue of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,365.4 Cr | -2.1% | 7.5% | 48.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -2.1% |
7.5% |
48.2% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses